Prelude Therapeutics Inc (PRLD) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-10
08:00 am
Purchase
2022-12-3113GPRELUDE THERAPEUTICS INC
PRLD
Vaddi Krishna4,299,323
11.300%
680,770increase
(+18.81%)
Filing
History
2023-02-09
12:31 pm
Sale
2023-02-0913GPRELUDE THERAPEUTICS INC
PRLD
FMR LLC4,589,591
9.589%
-1,349,341decrease
(-22.72%)
Filing
History
2022-02-09
10:24 am
Sale
2022-02-0813GPRELUDE THERAPEUTICS INC
PRLD
FMR LLC5,938,932
12.578%
-413,049decrease
(-6.50%)
Filing
History
2022-02-04
4:05 pm
Purchase
2021-12-3113GPRELUDE THERAPEUTICS INC
PRLD
Vaddi Krishna3,618,553
9.700%
680,781increase
(+23.17%)
Filing
History
Goto Prev, 0, 1